<DOC>
	<DOCNO>NCT00487968</DOCNO>
	<brief_summary>Based need pediatric formulation eltrombopag treatment pediatric thrombocytopenia , study help determine best taste pediatric formulation eltrombopag . Healthy adult volunteer able taste bitterness high sensitivity bitterness enrol . The subject evaluate different formulation rate base bitterness effectiveness sweetners . The outcome study help support decision new pediatric formulation eltrombopag .</brief_summary>
	<brief_title>Eltrombopag Taste Testing Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>healthy adult base medical evaluation responsible physician male female adult 18 55 year old female subject pregnant lactate female unable child must document medical verification female able child must negative pregnancy test capable give write informed consent Exclusion criterion : subject unable taste bitterness extrememly sensitive bitterness participate clinical trial within 30 day exposure four new medicine within 12 month prior first day dose history sensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>healthy adult volunteer</keyword>
	<keyword>eltrombopag</keyword>
</DOC>